Targeting protein tyrosine phosphatase non-receptor type 2 with a novel inhibitor for AML therapy

已完结 10 由 Lee 发布于 2024/7/10 12:33:26

DOI:10.1101/2024.05.07.592940
作者：Wenbin Kuang, Jinxin Jiang, Xiao Wang, Dawei Wang, Minghui Ji, Yasheng Zhu, Kai Yuan, Jiayu Ding, Wenmu Wang, Mingge Song, Wenjian Min, Fei Huang, Liping Wang, Wanjian Gu, Haiping Hao, Yibei Xiao, Peng Yang
文献类型：期刊论文
补充材料：只需要正文

Cold Spring Harbor Laboratory (CSH)

Abstract：Acute myeloid leukemia (AML) is a fatal disease characterized by a bleak prognosis. For over four decades, treatment options for AML have been constrained to administering high-dose cytotoxi

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Society of Clinical Oncology (ASCO)Discovery of HDM2010, a highly potent PTPN2 inhibitor for immunotherapy.